1. Altered platelet reactivity, coagulation, endothelial and inflammatory markers early after smoking cessation verified with cotinine plasma concentration. (3rd October 2022) Authors: Ramotowski, B; Undas, A; Budaj, A Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An association of low-density lipoproteins and fibrinolysis in patients with severe aortic stenosis- valvular expression of fibrinolytic proteins. (14th October 2021) Authors: Kopytek, M; Undas, A; Natorska, J Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antibodies to N-homocysteinylated albumin and haemoglobin in patients with rheumatoid arthritis: a potential new marker of disease severity. (January 2014) Authors: Nowakowska-Plaza, A; Potaczek, DP; Gluszko, P; Undas, A Journal: Scandinavian journal of rheumatology Issue: Volume 43:Number 1(2014) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome. (April 2018) Authors: Kopytek, M; Natorska, J; Undas, A Journal: Lupus Issue: Volume 27:Number 5(2018) Page Start: 812 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study. (January 2020) Authors: Malec, K; Broniatowska, E; Undas, A Journal: Lupus Issue: Volume 29:Number 1(2020) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Non-vitamin K antagonist oral anticoagulants (NOACs) attenuate valvular calcification in patients with severe aortic stenosis. (3rd October 2022) Authors: Kopytek, M; Tarasiuk, J; Wronski, S; Undas, A; Natorska, J Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation. Issue 6 (8th October 2007) Authors: Dimitrow, P P; Undas, A; Bober, M; Tracz, W; Dubiel, J S Journal: Heart Issue: Volume 94:Issue 6(2008) Page Start: e21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P4476Protein oxidation and cardiovascular disease in patients with type 2 diabetes. (28th August 2018) Authors: Bryk, A H; Konieczynska, M; Broniatowska, E; Undas, A Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P769Serum biomarkers and key carotid atherosclerotic plaque morphology parameters determined in vivo using a novel, fully-quantitative virtual histology image analysis algorithm. (15th July 2014) Authors: Musialek, P; Tekieli, L; Mazurek, A; Dabrowski, W; Stepien, E; Pieniazek, P; Kablak-Ziembicka, A; Zmudka, K; Undas, A; Podolec, P Journal: Cardiovascular research Issue: Volume 103(2014)Supplement 1 Page Start: S141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Rivaroxaban attenuates valvular inflammation and tissue remodeling in patients with severe aortic stenosis. (14th October 2021) Authors: Kopytek, M; Zabczyk, M; Undas, A; Natorska, J Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗